Literature DB >> 33099813

Perivascular epithelioid cell tumors (PEComa) of the gynecologic tract.

Jennifer A Bennett1, Esther Oliva2.   

Abstract

PEComas of the female genital tract are rare mesenchymal neoplasms that are most common in the uterus, but also may occur in other gynecologic locations. As they morphologically and immunohistochemically resemble smooth muscle tumors, distinction between the two entities is often challenging, and may be aided by molecular analysis. Thus far, two distinct molecular groups-classic PEComas with TSC mutations and TFE3-translocation associated PEComas with TFE3 fusions have been described. Recognition of the first group is imperative as these patients may benefit from targeted therapy with mTOR inhibitors, if malignant. This review will focus on recognition of the morphologic and immunophenotypic features of PEComas, as well as the role of molecular testing in their diagnosis and treatment, analysis of the different algorithms to predict behavior, and differential diagnosis.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  PEComa; TFE3; TSC; perivascular epithelioid cell tumor; uterus

Mesh:

Substances:

Year:  2020        PMID: 33099813     DOI: 10.1002/gcc.22908

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  2 in total

Review 1.  Tuberous Sclerosis Complex With Multiple Organ Tumors: Case Report and Literature Review.

Authors:  Xinhe Zhang; Xinping Zhong; Xuyong Lin; Xuedan Li; Haoyu Tian; Bing Chang; Ying Wang; Jing Tong; Ningning Wang; Dan Li; Xiuli Jin; Die Huang; Yanmeng Wang; Huipeng Cui; Lin Guan; Yiling Li
Journal:  Front Oncol       Date:  2022-07-19       Impact factor: 5.738

2.  Perirenal Perivascular Epithelioid Cell Tumor (PEcoma) with Pulmonary Micro Invasive Adenocarcinoma: A Case Report and Literature Review.

Authors:  Zhaoxun Li; Nan Hu; Yan Liao; Jingmei Liu
Journal:  Onco Targets Ther       Date:  2021-07-21       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.